These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


393 related items for PubMed ID: 18092805

  • 1. Synthesis of caprazamycin analogues and their structure--activity relationship for antibacterial activity.
    Hirano S, Ichikawa S, Matsuda A.
    J Org Chem; 2008 Jan 18; 73(2):569-77. PubMed ID: 18092805
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents.
    Hirano S, Ichikawa S, Matsuda A.
    Bioorg Med Chem; 2008 May 01; 16(9):5123-33. PubMed ID: 18375127
    [Abstract] [Full Text] [Related]

  • 3. Design and synthesis of diketopiperazine and acyclic analogs related to the caprazamycins and liposidomycins as potential antibacterial agents.
    Hirano S, Ichikawa S, Matsuda A.
    Bioorg Med Chem; 2008 Jan 01; 16(1):428-36. PubMed ID: 17904373
    [Abstract] [Full Text] [Related]

  • 4. Chemistry and structure-activity relationship of antibacterial nucleoside natural products.
    Ichikawa S, Matsuda A.
    Nucleic Acids Symp Ser (Oxf); 2008 Jan 01; (52):77-8. PubMed ID: 18776261
    [Abstract] [Full Text] [Related]

  • 5. Development of a highly beta-selective ribosylation reaction without using neighboring group participation: total synthesis of (+)-caprazol, a core structure of caprazamycins.
    Hirano S, Ichikawa S, Matsuda A.
    J Org Chem; 2007 Dec 21; 72(26):9936-46. PubMed ID: 18027965
    [Abstract] [Full Text] [Related]

  • 6. Triketones active against antibiotic-resistant bacteria: synthesis, structure-activity relationships, and mode of action.
    van Klink JW, Larsen L, Perry NB, Weavers RT, Cook GM, Bremer PJ, MacKenzie AD, Kirikae T.
    Bioorg Med Chem; 2005 Dec 15; 13(24):6651-62. PubMed ID: 16140015
    [Abstract] [Full Text] [Related]

  • 7. Catalytic asymmetric total synthesis of (+)-caprazol.
    Gopinath P, Wang L, Abe H, Ravi G, Masuda T, Watanabe T, Shibasaki M.
    Org Lett; 2014 Jun 20; 16(12):3364-7. PubMed ID: 24897294
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides.
    Ozden S, Karataş H, Yildiz S, Göker H.
    Arch Pharm (Weinheim); 2004 Oct 20; 337(10):556-62. PubMed ID: 15476288
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antibacterial activity of arylpiperazinyl oxazolidinones with diversification of the N-substituents.
    Jang SY, Ha YH, Ko SW, Lee W, Lee J, Kim S, Kim YW, Lee WK, Ha HJ.
    Bioorg Med Chem Lett; 2004 Aug 02; 14(15):3881-3. PubMed ID: 15225689
    [Abstract] [Full Text] [Related]

  • 11. Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria.
    Ii K, Ichikawa S, Al-Dabbagh B, Bouhss A, Matsuda A.
    J Med Chem; 2010 May 13; 53(9):3793-813. PubMed ID: 20405928
    [Abstract] [Full Text] [Related]

  • 12. Total synthesis of caprazol, a core structure of the caprazamycin antituberculosis antibiotics.
    Hirano S, Ichikawa S, Matsuda A.
    Angew Chem Int Ed Engl; 2005 Mar 11; 44(12):1854-6. PubMed ID: 15723431
    [No Abstract] [Full Text] [Related]

  • 13. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
    Lohray BB, Lohray VB, Srivastava BK, Kapadnis PB, Pandya P.
    Bioorg Med Chem; 2004 Sep 01; 12(17):4557-64. PubMed ID: 15358283
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
    Tanitame A, Oyamada Y, Ofuji K, Kyoya Y, Suzuki K, Ito H, Kawasaki M, Nagai K, Wachi M, Yamagishi J.
    Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2857-62. PubMed ID: 15125947
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel semisynthetic antibiotics from caprazamycins A-G: caprazene derivatives and their antibacterial activity.
    Takahashi Y, Igarashi M, Miyake T, Soutome H, Ishikawa K, Komatsuki Y, Koyama Y, Nakagawa N, Hattori S, Inoue K, Doi N, Akamatsu Y.
    J Antibiot (Tokyo); 2013 Mar 07; 66(3):171-8. PubMed ID: 23532021
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.